Mobile

A study to assess the pharmacokinetics of LCZ696 in subjects with hepatic impairment compared to matched healthy subjects

Update Il y a 4 ans
Reference: EUCTR2012-000983-27

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

This is a study to characterize the pharmacokinetics as well as safety and tolerability of a single oral dose of LCZ696 200 mg in subjects with mild and moderate hepatic impairment compared to matched healthy subjects.

Inclusion criteria

  • Mild and moderate hepatic impairment

Links